Cargando…
The impact of SARS-CoV-2 3CL protease mutations on nirmatrelvir inhibitory efficiency. Computational insights into potential resistance mechanisms
The use of antiviral drugs can promote the appearance of mutations in the target protein that increase the resistance of the virus to the treatment. This is also the case of nirmatrelvir, a covalent inhibitor of the 3CL protease, or main protease, of SARS-CoV-2. In this work we show how the by-resid...
Autores principales: | Ramos-Guzmán, Carlos A., Andjelkovic, Milorad, Zinovjev, Kirill, Ruiz-Pernía, J. Javier, Tuñón, Iñaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993853/ https://www.ncbi.nlm.nih.gov/pubmed/36908962 http://dx.doi.org/10.1039/d2sc06584c |
Ejemplares similares
-
Testing Affordable Strategies for the Computational
Study of Reactivity in Cysteine Proteases: The Case of SARS-CoV-2
3CL Protease Inhibition
por: Ramos-Guzmán, Carlos A., et al.
Publicado: (2022) -
Inhibition Mechanism of SARS‐CoV‐2 Main Protease with Ketone‐Based Inhibitors Unveiled by Multiscale Simulations: Insights for Improved Designs
por: Ramos‐Guzmán, Carlos A., et al.
Publicado: (2021) -
Unveiling the Mechanistic
Singularities of Caspases:
A Computational Analysis of the Reaction Mechanism in Human Caspase-1
por: Ramos-Guzmán, Carlos A., et al.
Publicado: (2023) -
A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design
por: Ramos-Guzmán, Carlos A., et al.
Publicado: (2021) -
Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance
por: Ip, Jonathan Daniel, et al.
Publicado: (2023)